Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution

• Egile Nagusiak: Fabrizio Calapai (Egilea), Carmen Mannucci (Egilea), Luigi Cardia (Egilea), Mariaconcetta Currò (Egilea), Gioacchino Calapai (Egilea), Emanuela Esposito (Egilea), Ilaria Ammendolia (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2023-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Psoriasis is a chronic inflammatory skin disease characterized by plaque formation. Interleukin (IL)‐23 is upregulated in psoriatic lesions and is thought to be a major regulator of the Th17 pathway in psoriasis pathogenesis. Three monoclonal antibodies targeting the IL‐23p19 subunit, gusel...